Abstract：
UNASSIGNED: Contraceptive methods are well-established in their ability to prevent pregnancy and increase individual agency in childbearing. Evidence suggests that contraceptives can also be used to treat adverse conditions associated with menstruation, including abnormal and prolonged uterine bleeding, heavy menstrual bleeding, painful menstruation, endometriosis, uterine fibroids, and premenstrual dysphoric disorders.This review investigates the effects of contraceptive techniques such as contraceptive pills, and long-acting reversible contraceptives (e.g. intrauterine devices, implants) on menstrual morbidity.
UNASSIGNED: Over ten databases with no geographical boundaries were searched from inception until October 2023. Study designs were one of the following types to be included: parallel or cluster randomised controlled trials, controlled clinical trials, controlled before and after studies, interrupted time series studies, cohort or longitudinal analyses, regression discontinuity designs, and case-control studies. Ten team members screened the papers in pairs with a Kappa score of more than 7, and Covidence was used. Conflicts were resolved by discussion, and the full papers were divided among the reviewers to extract the data from eligible studies.
UNASSIGNED: Hormonal contraceptives are considered a well-tolerated, non-invasive, and clinically effective treatment for abnormal and prolonged uterine bleeding, heavy menstrual bleeding, painful menstruation, endometriosis, uterine fibroids, and premenstrual dysphoric disorders. Our studies investigating quality of life or well-being in women with heavy menstrual bleeding, endometriosis, or uterine fibroids have found improvements in all dimensions assessed.
UNASSIGNED: Hormonal contraceptives significantly reduce pain, symptom severity, and abnormal bleeding patterns associated with women who suffer from heavy menstrual bleeding, endometriosis, and uterine fibroids.
Hormonal contraceptives significantly reduce pain, symptom severity, and abnormal bleeding patterns associated with women who suffer from heavy menstrual bleeding, endometriosis, and uterine fibroids. Findings can inform clinical practice and policy decisions to ensure that women have access to safe and effective contraceptive options that promote both reproductive and non-reproductive health.
UNASSIGNED: Over ten databases with no geographical boundaries were searched from inception until October 2023. Study designs were one of the following types to be included: parallel or cluster randomised controlled trials, controlled clinical trials, controlled before and after studies, interrupted time series studies, cohort or longitudinal analyses, regression discontinuity designs, and case-control studies. Ten team members screened the papers in pairs with a Kappa score of more than 7, and Covidence was used. Conflicts were resolved by discussion, and the full papers were divided among the reviewers to extract the data from eligible studies.
UNASSIGNED: Hormonal contraceptives are considered a well-tolerated, non-invasive, and clinically effective treatment for abnormal and prolonged uterine bleeding, heavy menstrual bleeding, painful menstruation, endometriosis, uterine fibroids, and premenstrual dysphoric disorders. Our studies investigating quality of life or well-being in women with heavy menstrual bleeding, endometriosis, or uterine fibroids have found improvements in all dimensions assessed.
UNASSIGNED: Hormonal contraceptives significantly reduce pain, symptom severity, and abnormal bleeding patterns associated with women who suffer from heavy menstrual bleeding, endometriosis, and uterine fibroids.
Hormonal contraceptives significantly reduce pain, symptom severity, and abnormal bleeding patterns associated with women who suffer from heavy menstrual bleeding, endometriosis, and uterine fibroids. Findings can inform clinical practice and policy decisions to ensure that women have access to safe and effective contraceptive options that promote both reproductive and non-reproductive health.
摘要：
■避孕方法在预防怀孕和增加生育个体的能力方面已经确立。有证据表明，避孕药也可用于治疗与月经相关的不良病症，包括异常和长时间的子宫出血，大量月经出血,痛苦的月经，子宫内膜异位症,子宫肌瘤,经前烦躁不安.这篇综述调查了避孕技术的效果，如避孕药，和长效可逆避孕药(例如宫内节育器，植入物)对月经发病率的影响。
■从开始到2023年10月，搜索了十个没有地理边界的数据库。研究设计包括以下类型之一：平行或集群随机对照试验，对照临床试验,在研究之前和之后进行控制，中断的时间序列研究，队列或纵向分析，回归不连续设计，和病例对照研究。十名团队成员成对筛选了论文，其Kappa得分超过7，并使用了Covidence。通过讨论解决了冲突，并在审稿人之间分配完整的论文，以从符合条件的研究中提取数据。
■荷尔蒙避孕药被认为是一种耐受性良好的避孕药，非侵入性，以及临床上对异常和长期子宫出血的有效治疗，大量月经出血,痛苦的月经，子宫内膜异位症,子宫肌瘤,经前烦躁不安.我们的研究调查了月经大量出血的女性的生活质量或幸福感，子宫内膜异位症,或子宫肌瘤在评估的所有维度都有改善。
■激素避孕药可显着减轻疼痛，症状严重程度,与患有大量月经出血的女性相关的异常出血模式，子宫内膜异位症,和子宫肌瘤.
激素避孕药显著减轻疼痛，症状严重程度,与患有大量月经出血的女性相关的异常出血模式，子宫内膜异位症,和子宫肌瘤.调查结果可以为临床实践和政策决定提供信息，以确保妇女能够获得安全有效的避孕选择，从而促进生殖健康和非生殖健康。
■从开始到2023年10月，搜索了十个没有地理边界的数据库。研究设计包括以下类型之一：平行或集群随机对照试验，对照临床试验,在研究之前和之后进行控制，中断的时间序列研究，队列或纵向分析，回归不连续设计，和病例对照研究。十名团队成员成对筛选了论文，其Kappa得分超过7，并使用了Covidence。通过讨论解决了冲突，并在审稿人之间分配完整的论文，以从符合条件的研究中提取数据。
■荷尔蒙避孕药被认为是一种耐受性良好的避孕药，非侵入性，以及临床上对异常和长期子宫出血的有效治疗，大量月经出血,痛苦的月经，子宫内膜异位症,子宫肌瘤,经前烦躁不安.我们的研究调查了月经大量出血的女性的生活质量或幸福感，子宫内膜异位症,或子宫肌瘤在评估的所有维度都有改善。
■激素避孕药可显着减轻疼痛，症状严重程度,与患有大量月经出血的女性相关的异常出血模式，子宫内膜异位症,和子宫肌瘤.
激素避孕药显著减轻疼痛，症状严重程度,与患有大量月经出血的女性相关的异常出血模式，子宫内膜异位症,和子宫肌瘤.调查结果可以为临床实践和政策决定提供信息，以确保妇女能够获得安全有效的避孕选择，从而促进生殖健康和非生殖健康。
